Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000884

Drug Information
NameRolitetracycline    
SynonymsTetracycline, pyrrolidinomethyl-; CHEMBL1214184; (2Z,4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-2-[hydroxy-(pyrrolidin-1-ylmethylamino)methylidene]-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione; Bristacin; SQ 15659; SQ 15,659; HMS2052O05; Synotodecin; Prestwick_1045; BSPBio_000837; Rolitetracycline [USAN:INN:BAN:JAN]; (4S,4aS,6S,12aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(pyrrolidin-1-ylmethyl)-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide; Velacycline; Rolitetracycline (JAN/USAN/INN); UNII-GH9IW85221; LS-93872; Synterin (TN); (2Z,4S,4aS,6S,12aS)-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-2-[hydroxy-(pyrrolidin-1-ylmethylamino)methylidene]-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione; NCGC00179407-01; D02282; 20685-78-3 (mononitrate); Prestwick1_000849; Prestwick3_000849; AAT 4; CID5282179; Rolitetracyclinum; Kinteto; BPBio1_000921; 751-97-3; Pirrolidinometil-tetraciclina [Italian]; Rolitetracyclinum [INN-Latin]; EINECS 212-031-9; Rolitetraciclina; SMR000058701; Tetracycline, N-(pyrrolidinylmethyl)-; R2253_SIGMA; Prestwick2_000849; Syntetrex; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)-; Tetraverin; Rolitetraciclina [INN-Spanish]; Pirrolidinometil-tetraciclina; 68060-64-0; N-(1-Pyrrolidinylmethyl)-tetracycline; Pyrrolidinomethyltetracycline; C27H33N3O8; Prm-TC; 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)-2-naphthacenecarboxamide; (2Z,4S,6S,12aS)-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-2-[hydroxy-(pyrrolidin-1-ylmethylamino)methylidene]-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione; Velacicline; CHEMBL436221; ROLITETRACYCLINE; Transcycline; ST075203; AC1NR4RN; Superciclin; R2253_FLUKA; Pyrrolidino-methyl-tetracycline; 7681-32-5 (nitrate); HMS1570J19; Solvocillin; n-Pyrrolidino-methyl-tetracycline; AC1O4WIV; MLS000028710; CPD000058701; Syntetrin; Synterin; Prestwick0_000849; SAM001246892; AC1NQZM8; Revrin; CID5284615; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)-, (4S-(4alpha,4aalpha,5aalpha,6beta,12aalpha))-; SPBio_002758; Reverin; DB01301; CID6420073; N-(Pyrrolidinomethyl)tetracycline    
IndicationBacterial infectionsApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntibacterial Agents    
CAS NumberCAS 751-97-3
FormularC27H33N3O8    
PubChem Compound IDCID 5284615.    
PubChem Substance IDSID 156301.    
SuperDrug ATC IDJ01AA09;    
SuperDrug CAS ID000751973;    
Target30S ribosomal subunitBinder[1]
Ref 1Reversed-phase high-performance liquid chromatography coupled to ultraviolet and electrospray time-of-flight mass spectrometry on-line detection for the separation of eight tetracyclines in honey samples. J Chromatogr A. 2008 Jun 27;1195(1-2):107-16. Epub 2008 May 10. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543